Nut Pusuntisumpun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nut Pusuntisumpun has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Bandhita Wanikorn
Kasetsart University
1 shared publication Massalin Nakphaichit
Department of Biotechnology, Faculty of Agro‐Industry Kasetsart University Bangkok 10900 Thailand
1 shared publication- Massalin Nakphaichit
Department of Biotechnology, Faculty of Agro-Industry, Kasetsart University, Bangkok 10900, Thailand
1 shared publication Paiboon Tunsagool
Department of Biotechnology, Faculty of Agro‐Industry Kasetsart University Bangkok 10900 Thailand
1 shared publication- Paiboon Tunsagool
Department of Biotechnology, Faculty of Agro-Industry, Kasetsart University, Bangkok 10900, Thailand
1 shared publication - Pornlada Yutharaksanukul
Department of Biotechnology, Faculty of Agro-Industry, Kasetsart University, Bangkok 10900, Thailand
1 shared publication
Latest Publications
- Open Access
Effects of Purified Vitexin and Iso-Vitexin from Mung Bean Seed Coat on Antihyperglycemic Activity and Gut Microbiota in Overweight Individuals’ Modulation
Exceeding a healthy weight significantly elevates the likelihood of developing type 2 diabetes (T2DM). A commercially available singular constituent, available as either purified vitexin or iso-vitexin, has been associated with a decreased risk of T2DM, but its synergistic effect has not been reported yet. Vitexin and iso-vitexin were extracted using an ethanol-based solvent from mung bean seed coat (MBCE) and subsequently purified using preparative liquid chromatography (Prep-LC). Eleven mixture ratios of vitexin and/or iso-vitexin were determined for their antioxidant and antihyperglycemic activities. The 1:1.5 ratio of vitexin to iso-vitexin from MBCE demonstrated the most synergistic effects for enzyme inhibition and glucose uptake in HepG2 cells within an insulin-resistant system, while these ratios exhibited a significantly lower antioxidant capacity than that of each individual component. In a gut model system, the ratio of 1:1.5 (vitexin and iso-vitexin) regulated the gut microbiota composition in overweight individuals by decreasing the growth of Enterobacteriaceae and Enterococcaceae, while increasing in Ruminococcaceae and Lachnospiraceae. The application of vitexin/iso-vitexin for 24 h fermentation enhanced a high variety of abundances of 21 genera resulting in five genera of Parabacteroides, Ruminococcus, Roseburia, Enterocloster, and Peptacetobacter, which belonged to the phylum Firmicutes, exhibiting high abundant changes of more than 5%. Only two genera of Proteus and Butyricicoccus belonging to Proteobacteria and Firmicutes decreased. The findings suggest that these phytochemicals interactions could have synergistic effects in regulating glycemia, through changes in antihyperglycemic activity and in the gut microbiota in overweight individuals. This optimal ratio can be utilized by industries to formulate more potent functional ingredients for functional foods and to create nutraceutical supplements aimed at reducing the risk of T2DM in overweight individuals.
Open AccessEffects of Purified Vitexin and Iso-Vitexin from Mung Bean Seed Coat on Antihyperglycemic Activity and Gut Microbiota in Overweight Individuals’ Modulation
Exceeding a healthy weight significantly elevates the likelihood of developing type 2 diabetes (T2DM). A commercially available singular constituent, available as either purified vitexin or iso-vitexin, has been associated with a decreased risk of T2DM, but its synergistic effect has not been reported yet. Vitexin and iso-vitexin were extracted using an ethanol-based solvent from mung bean seed coat (MBCE) and subsequently purified using preparative liquid chromatography (Prep-LC). Eleven mixture ratios of vitexin and/or iso-vitexin were determined for their antioxidant and antihyperglycemic activities. The 1:1.5 ratio of vitexin to iso-vitexin from MBCE demonstrated the most synergistic effects for enzyme inhibition and glucose uptake in HepG2 cells within an insulin-resistant system, while these ratios exhibited a significantly lower antioxidant capacity than that of each individual component. In a gut model system, the ratio of 1:1.5 (vitexin and iso-vitexin) regulated the gut microbiota composition in overweight individuals by decreasing the growth of Enterobacteriaceae and Enterococcaceae, while increasing in Ruminococcaceae and Lachnospiraceae. The application of vitexin/iso-vitexin for 24 h fermentation enhanced a high variety of abundances of 21 genera resulting in five genera of Parabacteroides, Ruminococcus, Roseburia, Enterocloster, and Peptacetobacter, which belonged to the phylum Firmicutes, exhibiting high abundant changes of more than 5%. Only two genera of Proteus and Butyricicoccus belonging to Proteobacteria and Firmicutes decreased. The findings suggest that these phytochemicals interactions could have synergistic effects in regulating glycemia, through changes in antihyperglycemic activity and in the gut microbiota in overweight individuals. This optimal ratio can be utilized by industries to formulate more potent functional ingredients for functional foods and to create nutraceutical supplements aimed at reducing the risk of T2DM in overweight individuals.
- 18 January 2024
- Published by Oxford University Press (OUP) in International Journal of Food Science and Technology
- Vol. 59 (3) , 1898-1910
Impacts of combining Limosilactobacillus reuteri KUB‐AC5 and Limosilactobacillus fermentum KUB‐D18 on overweight gut microbiota using a simulated human colon model
Summary: High‐fat diets lead to fat accumulation and contribute to the incidence of obesity, which has now become a global public health problem. High‐fat diets directly impact the microbial composition of the gastrointestinal tract, causing an imbalance in the gut microbiota. This study investigated the effect of probiotics Limosilactobacillus reuteri KUB‐AC5 and Limosilactobacillus fermentum KUB‐D18 in reducing the negative effects associated with the consumption of a high‐fat diet. Results of metagenomics analysis demonstrated that the probiotics regulated the abundance of Enterobacteriaceae, a recognised biomarker of gut dysbiosis. The other observation was the induction of beneficial microbes in the family Bifidobacteriaceae. Supplementation with probiotics in a high‐fat diet significantly reduced phenol, the toxic compound produced by gut microbes (P = 0.032), and promoted the production of beneficial metabolites, including trans‐cinnamic acid and L‐(−)‐3‐phenyllactic acid (P = 0.002 and 0.007, respectively). Results suggested the potential benefits of L. reuteri KUB‐AC5 and L. fermentum KUB‐D18 to alleviate the negative health risks of obesity associated with the consumption of a high‐fat diet. These probiotics offer potential benefits as future health management alternatives.
- 18 January 2024
- Published by Oxford University Press (OUP) in International Journal of Food Science and Technology
- Vol. 59 (3) , 1898-1910
Impacts of combining Limosilactobacillus reuteri KUB‐AC5 and Limosilactobacillus fermentum KUB‐D18 on overweight gut microbiota using a simulated human colon model
Summary: High‐fat diets lead to fat accumulation and contribute to the incidence of obesity, which has now become a global public health problem. High‐fat diets directly impact the microbial composition of the gastrointestinal tract, causing an imbalance in the gut microbiota. This study investigated the effect of probiotics Limosilactobacillus reuteri KUB‐AC5 and Limosilactobacillus fermentum KUB‐D18 in reducing the negative effects associated with the consumption of a high‐fat diet. Results of metagenomics analysis demonstrated that the probiotics regulated the abundance of Enterobacteriaceae, a recognised biomarker of gut dysbiosis. The other observation was the induction of beneficial microbes in the family Bifidobacteriaceae. Supplementation with probiotics in a high‐fat diet significantly reduced phenol, the toxic compound produced by gut microbes (P = 0.032), and promoted the production of beneficial metabolites, including trans‐cinnamic acid and L‐(−)‐3‐phenyllactic acid (P = 0.002 and 0.007, respectively). Results suggested the potential benefits of L. reuteri KUB‐AC5 and L. fermentum KUB‐D18 to alleviate the negative health risks of obesity associated with the consumption of a high‐fat diet. These probiotics offer potential benefits as future health management alternatives.